“EVALUATION OF CITALOPRAM AFFECTED THE GENERALIZED ANXIETY DISORDER PARTICIPANTS’ QUALITY OF LIFE”. 2023. International Research Journal of Pharmacy 14 (11): 21-25. https://doi.org/10.56802/kedfgd52.